> Stellate Ganglion Block — Mechanism, Trials & Evidence |

← All agents | ← Research tracker

Stellate Ganglion Block

PubChem entry

Evidence Summary

Evidence Level: Preliminary
Mechanism: Enrollment: Actual, Enrollment: Estimated, Sponsor Type: Other, Unknown / General
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 2 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.

Related Conditions

Long COVID (no page yet)

Clinical Trials

2 trial(s) registered

NCT07374562: Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial NA RECRUITING
NCT06253806: Stellate Ganglion Block for COVID-induced Parosmia PHASE2 COMPLETED

Key Studies / References